Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with<sup>131</sup>I-tositumomabRebecca Elstrom, Mark Kaminski, Paul J. Christos et al.|Leukemia & lymphoma/Leukemia and lymphoma|2014Cited by 14